Incannex Completes Acquisition of APIRx Pharmaceuticals to Aggregate the World’s Largest Portfolio of Patented Medicinal Cannabinoid Drug Formulations Aug 5, 2022 | ASX News, Incannex Healthcare (ASX:IHL)